Bone Marrow Tumors

This is a type of cancer that starts in the bone marrow. It's different from cancers that start elsewhere in the body. These cancers are called 'neoplasms' because they are abnormal growths.

Condition

What people with Bone Marrow Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Bone Marrow Tumors?

NameHow it went

About Bone Marrow Tumors

What It Is

Bone marrow tumors are collections of abnormal cells growing in the bone marrow, the spongy tissue inside bones such as the hips and thighbones where red blood cells, white blood cells and platelets are made. In most cases the tumor did not start there. It is a cancer from another part of the body, such as the breast, prostate or lung, that has spread (metastasized) into the marrow. When the marrow is widely involved, doctors may call it bone marrow metastasis or bone marrow carcinomatosis. This is different from cancers that begin in the marrow's own cells, such as leukemia, multiple myeloma and myelodysplastic syndromes. Those are separate diagnoses with their own tests and treatments. The distinction matters because a tumor that has spread to the marrow is treated as part of the cancer it came from. The main effect of a marrow tumor is crowding. As tumor cells take up space, the marrow makes fewer healthy blood cells. That can cause anemia (too few red blood cells, leading to tiredness and shortness of breath), low platelets (easy bruising or bleeding) and low white blood cells (more infections). Sometimes these blood count changes are the first sign that a cancer has spread, and occasionally they are the first sign that a cancer is present at all.

Causes & Risk Factors

Marrow tumors develop when cancer cells travel from an existing tumor through the bloodstream and settle in the marrow. The main risk factor is therefore having a cancer that can spread to bone. In adults, breast, prostate, lung and stomach cancers are the most frequently reported sources, and bladder and other digestive tract cancers can also spread there. Lymphoma can involve the marrow as well. In children, marrow spread is most often seen with neuroblastoma (a cancer of immature nerve cells), retinoblastoma (an eye cancer), Ewing sarcoma and rhabdomyosarcoma (cancers of bone and soft tissue) and medulloblastoma (a brain tumor). Marrow involvement often appears alongside spread to the bones themselves, but researchers have not found a reliable way to predict who will develop it. Having one of these cancers does not mean it will reach the marrow.

How It's Diagnosed

Suspicion usually starts with a complete blood count (CBC), a routine blood test that measures red cells, white cells and platelets. Low counts that are not explained by recent chemotherapy, bleeding or another cause can prompt a closer look, especially in someone with a known cancer. A blood smear, in which a specialist examines blood under a microscope, may show immature red and white cells that normally stay inside the marrow. This pattern suggests something is displacing the marrow, but it is not specific enough to confirm the diagnosis on its own. Confirmation comes from a bone marrow aspiration and biopsy, usually taken from the pelvic (hip) bone after the skin and bone surface are numbed. The aspiration draws out liquid marrow, and the biopsy removes a small solid core. Doctors prefer to do both together, because tumor cells can scar the marrow so that little or no liquid can be drawn. The test causes brief pain or pressure; some bleeding at the site is the usual risk, and serious bleeding or infection is very rare. Examining the sample shows whether tumor cells are present and helps identify the cancer they came from. That matters because marrow damage from earlier chemotherapy, or a myelodysplastic syndrome, can also lower blood counts and look similar on blood tests.

Treatment Options

Treatment is aimed at the original cancer, since the marrow tumor is part of it. Depending on the cancer type, that may mean chemotherapy, hormone therapy, targeted drugs or other treatment for that cancer. Marrow involvement complicates this: chemotherapy normally strains the marrow, and here the marrow is already struggling. Doctors therefore often start with reduced doses or smaller, more frequent doses and adjust as blood counts respond. In breast cancer, for example, weekly lower-dose chemotherapy is commonly used, and for breast cancer that grows in response to hormones such as estrogen and lacks extra amounts of the growth protein HER2 (hormone receptor-positive, HER2-negative), hormone therapy combined with targeted drugs called CDK4/6 inhibitors, such as palbociclib (Ibrance), which slow cancer cell division, is an option. When the cancer responds, blood counts can stabilize or recover. Supportive care runs alongside cancer treatment. Red blood cell and platelet transfusions can relieve tiredness and breathlessness and lower bleeding risk, and infections are treated promptly. Because marrow spread usually means advanced cancer, some people decide with their care team to focus on comfort and quality of life rather than further cancer treatment, particularly when earlier treatments have stopped working or they are too unwell for more. Most of what is known about treating marrow involvement comes from small studies, and major cancer guidelines give little specific direction, so choices are made case by case.

What to Expect

For solid cancers, spread to the marrow usually signals advanced disease, and the outlook is generally more serious than when the cancer has not reached the marrow. The course varies widely with the type of cancer, where else it has spread and how well it responds to treatment. In one recent study of 37 people with breast cancer, the median survival after marrow involvement was found was about a year (half lived longer, half shorter), and survival was longer when the cancer was limited to bone. These are small studies and cannot predict any one person's course. Day to day, low blood counts shape much of life. Tiredness, breathlessness with activity and bruising are common, and regular blood tests guide transfusions and treatment doses. When white cells are low, lowering infection risk matters: frequent hand washing, staying away from people who are sick and careful food safety are standard advice. It often helps to talk early with the care team, including a palliative care team that specializes in symptom relief, about goals, preferences and the support that may be needed at home.

When to Seek Help

If you have cancer and a blood test shows unexplained low counts, or you develop new tiredness, shortness of breath, easy bruising or tiny red spots on the skin, ask your care team whether marrow involvement or another cause should be checked. Tell the team between visits if these symptoms get worse, since counts may have dropped and a transfusion or treatment change may be needed. Call your care team right away for a fever of 100.5°F (38°C) or higher, chills or other signs of infection, especially if your white cell count is low or you are on cancer treatment. Infections in this situation can be life threatening and need urgent attention. Check with the team before taking fever-reducing medicine, because it can hide a fever. Also call your care team right away for serious bleeding: bleeding that does not stop after a few minutes of pressure, blood when you vomit, black or bloody stools, red or pink urine, or a bad headache, vision change or confusion. When platelets are low, ask the team before taking aspirin or ibuprofen, which can raise bleeding risk.

Questions to Ask Your Doctor

  1. 1.Has the tumor in my marrow spread from a known cancer, and how was that confirmed?
  2. 2.How do my blood counts affect which treatments and doses are safe for me?
  3. 3.What would a good response look like, and how will we track it?
  4. 4.When might I need a transfusion, and which symptoms should prompt a call to you?
  5. 5.Can we talk about my goals now and involve a palliative care team for symptom support?

Last reviewed • Oct 2026

Educational content, not medical advice.